VistaGen Therapeutics
South San Francisco, US
Biotech
Founders & leadership
JS
Jon S. SaxeDirector
UJ
Underdown J. BrianDirector
HR
H. Ralph SnodgrassExecutive Officer, Director
JD
Jerrold D. DotsonExecutive Officer
SK
Shawn K. SinghExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$2.8MofferedFeb 2023 · 129 investors · Pharmaceuticals
Rule 506(b)$2.8MraisedJan 2020 · 3 investors · Pharmaceuticals
Rule 506(b)$650KraisedDec 2019 · 7 investors · Biotechnology
Rule 506(b)$4.8MraisedSep 2018 · 33 investors · Biotechnology
Rule 506(b)$1MraisedAug 2017 · 14 investors · Biotechnology
Rule 506(b)$1.9MraisedAug 2015 · 15 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.